January 18, 2024
Panbela Announces Publication of Clinical Data: A New Approaches to Neuroblastoma Therapy Trial
Panbela Announces Publication of Clinical Data Titled:
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
- A Phase 1 clinical study showed that high dose DFMO treatment in combination with chemotherapy may provide therapeutic benefits to heavily pretreated patients with neuroblastoma.